Skip Ribbon Commands
Skip to main content
Sign In
Navigate Up

23466 Diphtheria Tetanus Antibody Panel (DTABS)

Diphtheria Tetanus Antibody Panel (DTABS)
Test Code: DIPTESO
Synonyms/Keywords
Anti-tetanus toxoid, C. tetani, Clostridium tetani, Corynebacterium diphtheriae Antitoxin, Diphtheria Antitoxoid, Tetanus Immune Response, Tetanus toxoid antibodies, Tetanus/Diphtheria Antibody Panel
Test Components
​Diphtheria Toxoid IgG Antibody
Tetanus Toxoid IgG Antibody
Useful For
​Determining the vaccination status of individuals to diphtheria and tetanus toxoid.
Specimen Requirements
Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)		 Pediatric Minimum Volume
(no repeat)
Serum​ ​Red Top Tube (RTT) ​Serum Separator Tube (SST) ​1 mL ​0.8 mL ​
Specimen Stability Information
Specimen Type Temperature Time
​Serum ​ ​Refrigerated (preferred) ​14 days
​Frozen ​14 days
Rejection Criteria
​​Gross Hemolysis
Gross ​Lipemia
​Gross Icterus
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
​Mayo Medical Laboratories Monday through Friday​ ​Same day/1 day
Enzyme Immunoassay (EIA)​
Reference Lab
Mayo Clinic Laboratories
Test Information

This test should be regarded as 'Research Use Only'. This test has not been cleared or approved by the U.S. Food and Drug Administration. It may not be covered by insurance and providers need to inform all patients of this prior to ordering. 

For Medicare patients, an Advanced Beneficiary notice (ABN) is required; for Medicaid patients, a Noncovered Services Waiver is required, and for commercial payers, prior authorization should be obtained.   ​

Reference Range Information

DIPHTHERIA TOXOID IgG ANTIBODY ASSAY
The minimum level of protective antibody in the normal population is between 0.01 and 0.1 IU/mL.  The majority of vaccinated individuals should demonstrate protective levels of antibody >0.1 IU/mL.

TETANUS TOXOID IgG ANTIBODY ASSAY
The minimum level of protective antibody in the normal population is between 0.01 and 0.15 IU/mL. The majority of vaccinated individuals should demonstrate protective levels of antibody >0.15various fields  IU/mL.

Outreach CPTs
CPT Modifier
(if needed)		 Quantity Description Comments
​86317 ​ ​2 ​
Classification

This test should be regarded as 'Research Use Only'. This test has not been cleared or approved by the U.S. Food and Drug Administration. It may not be covered by insurance and providers need to inform all patients of this prior to ordering. 

For Medicare patients, an Advanced Beneficiary notice (ABN) is required; for Medicaid patients, a Noncovered Services Waiver is required, and for commercial payers, prior authorization should be obtained.   ​

Synonyms/Keywords
Anti-tetanus toxoid, C. tetani, Clostridium tetani, Corynebacterium diphtheriae Antitoxin, Diphtheria Antitoxoid, Tetanus Immune Response, Tetanus toxoid antibodies, Tetanus/Diphtheria Antibody Panel
Test Components
​Diphtheria Toxoid IgG Antibody
Tetanus Toxoid IgG Antibody
Ordering Applications
Ordering Application Description
​Centricity ​Diphtheria Tetanus Ab
​Cerner ​Diphtheria Tetanus Antibody Panel (83269)
​COM ​Diphtheria Tetanus Ab Panel
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)		 Pediatric Minimum Volume
(no repeat)
Serum​ ​Red Top Tube (RTT) ​Serum Separator Tube (SST) ​1 mL ​0.8 mL ​
Specimen Stability Information
Specimen Type Temperature Time
​Serum ​ ​Refrigerated (preferred) ​14 days
​Frozen ​14 days
Rejection Criteria
​​Gross Hemolysis
Gross ​Lipemia
​Gross Icterus
Useful For
​Determining the vaccination status of individuals to diphtheria and tetanus toxoid.
Test Components
​Diphtheria Toxoid IgG Antibody
Tetanus Toxoid IgG Antibody
Reference Range Information

DIPHTHERIA TOXOID IgG ANTIBODY ASSAY
The minimum level of protective antibody in the normal population is between 0.01 and 0.1 IU/mL.  The majority of vaccinated individuals should demonstrate protective levels of antibody >0.1 IU/mL.

TETANUS TOXOID IgG ANTIBODY ASSAY
The minimum level of protective antibody in the normal population is between 0.01 and 0.15 IU/mL. The majority of vaccinated individuals should demonstrate protective levels of antibody >0.15various fields  IU/mL.

For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
​Mayo Medical Laboratories Monday through Friday​ ​Same day/1 day
Enzyme Immunoassay (EIA)​
Reference Lab
Mayo Clinic Laboratories
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)		 Quantity Description Comments
​86317 ​ ​2 ​
Classification

This test should be regarded as 'Research Use Only'. This test has not been cleared or approved by the U.S. Food and Drug Administration. It may not be covered by insurance and providers need to inform all patients of this prior to ordering. 

For Medicare patients, an Advanced Beneficiary notice (ABN) is required; for Medicaid patients, a Noncovered Services Waiver is required, and for commercial payers, prior authorization should be obtained.   ​

For most current information refer to the Marshfield Laboratory online reference manual.